Cargando…
Nicotinic acid/laropiprant reduces platelet count but increases mean platelet volume in patients with primary dyslipidemia
INTRODUCTION: Nicotinic acid (NA) has been associated with reduced cardiovascular morbidity and mortality. Of note, beyond its lipid-modifying actions, NA possesses a number of not yet thoroughly defined pleiotropic actions including anti-inflammatory and antithrombotic effects. As a growing body of...
Autores principales: | Kei, Anastazia, Elisaf, Moses |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4107250/ https://www.ncbi.nlm.nih.gov/pubmed/25097572 http://dx.doi.org/10.5114/aoms.2014.43738 |
Ejemplares similares
-
Add-on-Statin Extended Release Nicotinic Acid/Laropiprant but Not the Switch to High-Dose Rosuvastatin Lowers Blood Pressure: An Open-Label Randomized Study
por: Kei, Anastazia, et al.
Publicado: (2011) -
Mean Platelet Volume and Mean Platelet Volume/Platelet Count Ratio in Chronic Urticaria
por: Yim, June Hyuck, et al.
Publicado: (2019) -
Anacetrapib, a New CETP Inhibitor: The New Tool for the Management of Dyslipidemias?
por: Filippatos, Theodosios D., et al.
Publicado: (2017) -
Platelet Count and Mean Platelet Volume in Psoriasis Patients
por: Özkur, Ezgi, et al.
Publicado: (2018) -
Mean platelet volume and mean platelet volume/platelet count ratio in risk stratification of pulmonary embolism
por: Yardan, T, et al.
Publicado: (2015)